Death in a vial: Five cases lay bare many uncomfortable truths about Indian healthcare

Five young mothers in Kota died after childbirth, with suspicion falling on oxytocin injections. Investigations revealed the vials contained only water, not the active ingredient. The manufacturer, Jackson Laboratories, has had stop-production orders earlier as well. This incident has put focus on critical failures in drug regulation and raises serious concerns about patient safety.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/iaItPh9
via IFTTT

Read More

Adani Group to set up 2,000-bed hospital in New Town: Bengal CM

West Bengal Chief Minister Suvendu Adhikari announced that the Adani Group will establish a 2,000-bed hospital in New Town. A significant portion, 1,000 beds, will be dedicated to providing free treatment for the underprivileged. The remaining beds will be utilized for commercial operations. This initiative was revealed during an interaction with civil society members, highlighting the government's recent efforts.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MkG8EVN
via IFTTT

Read More

OnCare launches cancer treatment centre in Bengaluru

Bengaluru now has a new cancer treatment centre launched by OnCare, aiming to bring accessible, affordable, and patient-friendly oncology services to the region. Following success in Delhi-NCR, the facility offers comprehensive care including chemotherapy, immunotherapy, and supportive services.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/4oBSebW
via IFTTT

Read More

Fortis Healthcare inks pact with Dion Group for 300-bed hospital in Cuttack

Fortis Healthcare is set to manage and operate a new 300-bed multi-specialty hospital in Cuttack, Odisha, a project valued at Rs 600 crore. Developed by Dion Group, the facility aims to significantly enhance access to advanced tertiary care for residents of Cuttack, Bhubaneswar, and surrounding areas. This collaboration merges Fortis's extensive healthcare expertise with Dion's infrastructure development vision, promising quality medical services closer to home.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mTuJNxy
via IFTTT

Read More

Sun Pharma secures relief in 'Pantocid' trademark dispute

Delhi High Court has halted Ahmedabad-based Finecure Pharmaceuticals from producing and selling drugs with names similar to Sun Pharma's 'Pantocid'. The court permitted Finecure to sell existing stock of 'Pantopacid' within four months, provided an affidavit detailing the inventory is filed. This decision overturns a previous ruling that had refused to grant an injunction against Finecure, highlighting significant sales disparities between the two companies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/j2dpVz7
via IFTTT

Read More

Syngene International MD & CEO Peter Bains resigns

Bains has resigned from the position of MD & CEO with effect from the close of business hours on June 30, Syngene International said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/YdApZaN
via IFTTT

Read More

Zydus Lifesciences ties up with Apollo Hospitals to offer Shield multi-cancer detection test

Zydus Lifesciences has partnered with Apollo Hospitals to introduce the Shield multi-cancer detection test in India, made possible through an agreement with Guardant Health. This innovative blood test can identify signals for multiple cancer types in individuals aged 45 and above. The collaboration aims to enhance early cancer detection and improve patient outcomes across the nation, making advanced screening more accessible.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/7sBNd9h
via IFTTT

Read More